Pregnancy alters maternal physiology, which drastically changes how drugs are absorbed, distributed, metabolized, and excreted. Nurses must understand these shifts to appreciate why standard adult drug doses often fail or cause toxicity during gestation.
A teratogen is any agent that can cause a birth defect or alter structural and functional development of the fetus. Vulnerability is highest during the first trimester, the period of organogenesis, when major organ systems are actively forming.
Historically, the FDA categorized drugs from A to X based on teratogenic risk, though clinical practice now shifts toward narrative risk summaries under the Pregnancy and Lactation Labeling Rule (PLLR). Regardless of the classification system used, nurses must verify safety profiles before administering any medication to a pregnant patient.
Managing the timing of childbirth requires drugs that either stimulate or suppress uterine smooth muscle contractions.
Labor pain is severe and multidimensional, driven by uterine muscle ischemia, cervical dilation, and stretching of the pelvic floor. Pharmacological management ranges from systemic opioids to regional neuraxial blocks.
Systemic agents like pethidine or tramadol cross the placenta and can cause neonatal respiratory depression if delivery occurs too soon after administration. Regional techniques, such as epidural and spinal anesthesia, block pain transmission locally while allowing the mother to remain awake. Nurses must monitor for maternal hypotension, which is a frequent and dangerous complication of regional blocks due to sympathetic nerve blockade.
The puerperium is the postpartum period where the body returns to its pre-pregnant state. Medications during this time often address postpartum pain, contraception, lactation suppression or promotion, and infection prevention.
When a mother chooses to breastfeed, drug transfer into breast milk becomes a primary clinical concern. Most drugs pass into milk via passive diffusion. Factors increasing infant risk include high lipid solubility, low molecular weight, and poor maternal protein binding. Drugs with a long half-life or active metabolites should be avoided, and nurses should consult lactation safety databases before administration.
Administering medications during pregnancy, labour, and the puerperium demands vigilance because every pharmacological choice impacts two patients: the mother and the developing fetus or newborn.
Nurses must perform rigorous baseline assessments, calculate weight-based dosages accurately, monitor maternal vital signs and fetal heart rate patterns, and recognize early signs of adverse reactions. Patient education must be clear, culturally sensitive, and focused on compliance, potential side effects, and the importance of avoiding over-the-counter or herbal remedies without professional guidance.